55 related articles for article (PubMed ID: 38596356)
1. Clinical outcomes of COVID-19 in patients with sickle cell disease in French Guiana.
Elenga N; Ntab B; Mafema Missindu J; Thomas Boizan N; Abassi A
Heliyon; 2024 Jun; 10(11):e32017. PubMed ID: 38868053
[TBL] [Abstract][Full Text] [Related]
2. Real-world evidence of the burden of sickle cell disease: a 5-year longitudinal study at a Brazilian reference center.
Barros GDS; Leal CVF; Leite LAC; Fujimoto DE; Cançado RD
Hematol Transfus Cell Ther; 2024; 46(2):161-166. PubMed ID: 38307824
[TBL] [Abstract][Full Text] [Related]
3. Homozygous Sickle Cell Disease after Age of 40: Follow-Up of a Cohort of 209 Patients in Senegal, West Africa.
Seck M; Dabo MA; Bousso ES; Keita M; Touré SA; Guèye SM; Faye BF; Dieng F; Diop S
Adv Hematol; 2024; 2024():7501577. PubMed ID: 38356903
[TBL] [Abstract][Full Text] [Related]
4. Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease.
Weaver SB; Rungkitwattanakul D; Singh D
J Pharm Pract; 2023 Feb; 36(1):139-148. PubMed ID: 34151636
[TBL] [Abstract][Full Text] [Related]
5. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
[TBL] [Abstract][Full Text] [Related]
6. Impact of hospitalized vaso-occlusive crises in the previous calendar year on mortality and complications in adults with sickle cell disease: a French population-based study.
Arlet JB; Herquelot E; Lamarsalle L; Raguideau F; Bartolucci P
Lancet Reg Health Eur; 2024 May; 40():100901. PubMed ID: 38596356
[TBL] [Abstract][Full Text] [Related]
7. Impact of Hydroxyurea Therapy in Reducing Pain Crises, Hospital Admissions, and Length of Stay Among Sickle Cell Patients in the Eastern Region of Saudi Arabia.
Albohassan H; Ammen M; Alomran AA; Bu Shehab H; Al Sakkak H; Al Bohassan A
Cureus; 2022 Nov; 14(11):e31527. PubMed ID: 36540486
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study.
Shah N; Bhor M; Xie L; Halloway R; Arcona S; Paulose J; Yuce H
J Health Econ Outcomes Res; 2019; 6(3):106-117. PubMed ID: 32685584
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and disease burden of sickle cell disease in France: A descriptive study based on a French nationwide claim database.
Leleu H; Arlet JB; Habibi A; Etienne-Julan M; Khellaf M; Adjibi Y; Pirenne F; Pitel M; Granghaud A; Sinniah C; De Montalembert M; Galacteros F
PLoS One; 2021; 16(7):e0253986. PubMed ID: 34242255
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes in patients with sickle cell disease and frequent vaso-occlusive crises.
Prasad R; Hasan S; Castro O; Perlin E; Kim K
Am J Med Sci; 2003 Mar; 325(3):107-9. PubMed ID: 12640284
[TBL] [Abstract][Full Text] [Related]
12. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021.
GBD 2021 Sickle Cell Disease Collaborators
Lancet Haematol; 2023 Aug; 10(8):e585-e599. PubMed ID: 37331373
[TBL] [Abstract][Full Text] [Related]
13. [Sickle cell disease imposes itself to French internists in the 21st century].
Arlet JB
Rev Med Interne; 2023 Jul; 44(7):325-327. PubMed ID: 37246036
[No Abstract] [Full Text] [Related]
14. Severity and burden of sickle cell disease in France: a nationwide real-world study.
Brousse V; Bernaudin F; Melaine A; Goguillot M; Gallagher M; Benard S; Habibi A
Haematologica; 2023 Sep; 108(9):2476-2486. PubMed ID: 36924235
[TBL] [Abstract][Full Text] [Related]
15. [Acute chest syndrome in adult sickle cell patients].
Cheminet G; Mekontso-Dessap A; Pouchot J; Arlet JB
Rev Med Interne; 2022 Aug; 43(8):470-478. PubMed ID: 35810055
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
